Sanofi and Blueprint Medicines, a U.S.-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis, a rare immunological disease, and other KIT-driven diseases, have ...

Sanofi SAN-0.18 % decrease; red down pointing triangle agreed to buy Blueprint Medicines BPMC 0.16 % increase; green up pointing triangle for up to $9.5 billion, the French drugmaker’s biggest ...

Sanofi also said that it would increase the number of Phase 3 studies it is conducting by 50% between 2023 and 2025.

Finding companies that have all the right stuff can produce winners. Everyone would love to find the perfect stock. But will you ever really find a stock that gives you everything you could ...

It's hard to find two companies that look as perfect a match as Bristol-Myers Squibb and Sanofi-Aventis. That's why rumors the pharmaceutical groups may consummate their relationship look credible ...

Sanofi and CD&R are joining forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the ...

Sanofi is battling multiple ailments. The $115 billion French pharma group on Friday forecast “low single digit” growth in earnings per share for 2023, disappointing analysts. Chief Executive ...

Every investor would love to stumble upon the perfect stock. But will you ever really find a stock that provides everything you could possibly want? One thing's for sure: You'll never discover ...

French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted by an earlier-than-anticipated start of the vaccination season.

Sanofi today announces the formal opening of the company's new flagship US offices, unveiling a state-of-the-art modern workplace fostering collaboration and innovation with the ultimate goal of ...

Sanofi’s shares fell following mixed results of its experimental drug for a deadly lung condition. Itepekimab, a medicine that is being jointly developed by Sanofi and Regeneron, is being tested ...

Coca-Cola Co. is partnering with French drug manufacturer Sanofi SA to introduce a line of drinks that claim to help improve skin, strengthen hair and even help with weight loss. By Amy Wicks ...